塩野義、調達業務の9割で効率化を期待 AI自動化が本格化

Japan's procurement landscape is entering a period of AI-driven transformation, as global and domestic SaaS vendors move to embed artificial intelligence capabilities into their platforms. The shift reflects a broader recognition that procurement—historically handled by human teams managing vendor relationships, cost analysis, and contract execution—is now a candidate for large-scale automation and decision support through AI.

Major SaaS vendors serving procurement functions worldwide are already integrating AI features into their services, and this wave is reaching Japan. Domestic vendors are set to begin rolling out AI-powered procurement offerings from the latter half of 2026 onward, creating a window for Japanese enterprises to adopt and implement these new tools.

Shionogi Pharma is among the first large Japanese corporations to signal serious interest in AI-based procurement transformation. The company is evaluating how AI can reshape its procurement operations, and it expects AI to unlock efficiency improvements across roughly 90% of its procurement tasks. This ambitious scope—rather than targeting only a subset of workflows—underscores the potential for AI to redesign how procurement professionals work across vendor selection, cost optimization, contract management, and compliance. The move reflects confidence that AI can deliver both productivity gains and improved work quality, addressing traditional pain points in manual procurement operations.

The article signals a turning point in how enterprises handle procurement—a traditionally labor-intensive function that SaaS vendors have long sought to streamline through software. The shift to AI represents a qualitative leap: rather than simply automating repetitive tasks through rules-based workflows, AI can now handle the judgment and pattern-matching that human procurement officers perform, such as vendor evaluation, cost negotiation, and risk assessment.

The timing of this rollout—concentrated in the latter half of 2026—suggests a coordinated wave of product launches by major SaaS vendors responding to proven demand. Shionogi Pharma's public exploration of AI procurement adoption signals that Japan's large enterprises are ready to pilot and evaluate these tools, validating the business case for vendors to invest in Japanese-language and Japan-adapted versions. The stated expectation of efficiency gains across 90% of procurement workflows indicates that vendors and customers are not merely automating the low-hanging fruit, but redesigning entire procurement pipelines around AI decision support.

No comments yet. Be the first to share your thoughts!